Sang­amo cuts 120 jobs, an­nounces pri­or­i­tized pipeline to ex­tend cash run­way an­oth­er year

Sang­amo Ther­a­peu­tics is cut­ting 27% of its US work­force, pri­or­i­tiz­ing its pipeline and chang­ing up its cor­po­rate struc­ture in or­der to save about $31 mil­lion and stay afloat for the next 12 months.

The cell and gene ther­a­py biotech said Wednes­day it will lay off 120 peo­ple as it re­duced its in­ter­nal man­u­fac­tur­ing and al­lo­gene­ic re­search work in Cal­i­for­nia. An­drew Ramelmeier, EVP of tech­ni­cal op­er­a­tions, will al­so be leav­ing the com­pa­ny in Ju­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.